EpirubicinAntibiotics, AntineoplasticAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideFluorouracilDrug Administration ScheduleBreast NeoplasmsToxicity TestsPaclitaxelTaxoidsTreatment OutcomeRazoxaneCisplatinChemotherapy, AdjuvantDoxorubicinInfusions, IntravenousDeoxycytidineDose-Response Relationship, DrugDisease-Free SurvivalVinblastineToxicity Tests, AcuteGranulocyte Colony-Stimulating FactorAntineoplastic AgentsNeoadjuvant TherapyAnthracyclinesSurvival AnalysisNeutropeniaLethal Dose 50MethotrexateSurvival RateAlopeciaHematologic DiseasesLeukopeniaIfosfamideCombined Modality TherapyTime FactorsAdministration, OralNeoplasm MetastasisNeoplasm StagingNauseaMaximum Tolerated DoseDrug EvaluationInjections, IntravenousVomitingCarboplatinProlyl HydroxylasesAntineoplastic Agents, PhytogenicEtoposideAdenocarcinomaNeoplasmsStomach NeoplasmsStomatitisArea Under CurveVincristineDrug InteractionsNaphthacenesFollow-Up StudiesDrug Resistance, NeoplasmAntimetabolites, AntineoplasticLung NeoplasmsHeart DiseasesProspective StudiesLeucovorinNeoplasm Recurrence, LocalReceptor, erbB-2Antineoplastic Agents, AlkylatingMastectomy, Radical